The FDA has approved a new generic version of Diovan (Novartis) that does not contain NDMA or NDEA, 2 potentially carcinogenic impurities identified in several recalled valsartan products.
Docosahexaenoic acid supplements given to mothers during pregnancy may lower systolic and diastolic blood pressure associated with overweight and obesity in their children.
Remote blood pressure monitoring by a smartphone app effectively reduces systolic blood pressure at 6 weeks.
Women with a history of hypertensive disorders of pregnancy have a greater long-term risk for stroke reduced by aspirin use.
PDL BioPharma has announced the availability of an authorized generic version of Tekturna (aliskiren hemifumarate; Noden Pharma).
The American Heart Association has updated its scientific statement on blood pressure readings.
Candesartan plus hydrochlorothiazide, rosuvastatin, or their combination do not impact cognitive decline among older people.
In sedentary overweight/obese older adults, morning exercise reduces systolic blood pressure, with additional benefit seen by combining exercise with regular breaks in sitting.
A recently published report describes the case of a 59-year-old male patient who experienced olmesartan-associated enteropathy and highlights the importance of performing thorough medication reviews.
Researchers evaluated the relationship between low-density lipoprotein cholesterol and cardiovascular outcomes in patients with hypertension at increased cardiovascular risk.